Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
dongjiu ye
(8 results)?
LAIR1-mediated resistance of hepatocellular carcinoma cells to T cells through a GSK-3β/β-catenin/MYC/PD-L1 pathway.
Cell Signal. 2024 Mar;115:111039. doi: 10.1016/j.cellsig.2024.111039. Epub 2024 Jan 8.
Cell Signal. 2024.
PMID: 38199599
A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma.
Pan B, Luo Y, Ye D, Qiu J, Zhang X, Wu X, Yao Y, Wang X, Tang N.
Pan B, et al. Among authors: ye d.
Cancer Immunol Immunother. 2023 Dec;72(12):4103-4119. doi: 10.1007/s00262-023-03546-9. Epub 2023 Sep 27.
Cancer Immunol Immunother. 2023.
PMID: 37755466
Free PMC article.
Item in Clipboard
CSformer: Bridging Convolution and Transformer for Compressive Sensing.
Ye D, Ni Z, Wang H, Zhang J, Wang S, Kwong S.
Ye D, et al.
IEEE Trans Image Process. 2023;32:2827-2842. doi: 10.1109/TIP.2023.3274988. Epub 2023 May 22.
IEEE Trans Image Process. 2023.
PMID: 37186533
Item in Clipboard
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma.
Chen H, Lin R, Lin W, Chen Q, Ye D, Li J, Feng J, Cheng W, Zhang M, Qi Y.
Chen H, et al. Among authors: ye d.
Sci Rep. 2022 May 17;12(1):8230. doi: 10.1038/s41598-022-12301-6.
Sci Rep. 2022.
PMID: 35581376
Free PMC article.
Item in Clipboard
Correction to: A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma.
Pan B, Luo Y, Ye D, Qiu J, Zhang X, Wu X, Yao Y, Wang X, Tang N.
Pan B, et al. Among authors: ye d.
Cancer Immunol Immunother. 2023 Dec;72(12):4121-4122. doi: 10.1007/s00262-023-03576-3.
Cancer Immunol Immunother. 2023.
PMID: 37973661
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite